S. 1114, the Clean Sports Act of 2005, and S. 1334, the Professional Sports Integrity and Accountability Act: Hearing Before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Ninth Congress, First Session, September 28, 2005, Volume 4 |
Other editions - View all
Common terms and phrases
agree anabolic steroids ANTONIO DAVIS appropriate banned substances baseball players believe BETTMAN bills blood tests Chairman Clean Sports Act Commissioner SELIG Commissioner TAGLIABUE Committee Congress doping Drug Free Sport drug testing drug-testing program effective Federal FEHR gram Hank Aaron hearing home run human growth hormone independent issue laboratory League Players list of prohibited Lou Brock Major League Baseball mandatory ment National Football League National Hockey League negotiations NHL players NHLPA off-season testing Olympic penalties performance-enhancing drugs performance-enhancing substances play player who tested Players Association positive test results PREPARED STATEMENT problem professional athlete Prohibited Substances proposed legislation question Robin Roberts SABH Program season Senator BUNNING Senator CANTWELL Senator DORGAN Senator LAUTENBERG Senator MCCAIN stances steroids and performance-enhancing strict liability Substance Abuse suspension testing program Thank therapeutic use exemption things tion U.S. SENATOR Upshaw USADA violation WADA young
Popular passages
Page 42 - Corticotrophins Unless the Athlete can demonstrate that the concentration was due to a physiological or pathological condition, a Sample will be deemed to contain a Prohibited Substance (as listed above) where the concentration of the Prohibited Substance or its metabolites and/or relevant ratios or markers in the Athlete's Sample so exceeds the range of values normally found in humans so as not to be consistent with normal endogenous production. The presence of analogues, mimetics, diagnostic marker(s)...
Page 42 - ... listed above) where the concentration of the Prohibited Substance or its metabolites and/or relevant ratios or markers in the Athlete's Sample so exceeds the range of values normally found in humans so as not to be consistent with normal endogenous production. The presence of analogues, mimetics, diagnostic marker(s) or releasing factors of a hormone listed above or of any other finding which indicate(s) that the substance detected is not the naturally present hormone, will be reported as an...
Page 42 - T/E ratio greater than six (6) to one (1) in the urine, further investigation is obligatory in order to determine whether the ratio is due to a physiological or pathological condition. In both cases, the investigation will include a review of any previous tests, subsequent tests and/or results of endocrine investigations. If previous tests are not available, the Athlete shall undergo an endocrine investigation or be tested unannounced at least three times within a three month period.
Page 42 - In all cases, and at any concentration, the laboratory will report a adverse finding if, based on any reliable analytical method, it can show that the Prohibited Substance is of exogenous origin. If the laboratory result is not conclusive and no concentration as referred to in the above paragraph is found, the relevant Anti-Doping Organization shall conduct a further investigation if there are serious indications, such as a comparison to reference steroid profiles, for a possible Use of a Prohibited...
Page 25 - Association, and the Institute for the Study of Youth Sports at Michigan State University. Two of the four volumes of this series deal with the matters of direct interest to this Committee. One volume specifically discusses "Strength and Conditioning...
Page 42 - ... and/or any other relevant ratio(s) in the Athlete's Sample so deviates from the range of values normally found in humans so as not to be consistent with normal endogenous production. A Sample shall not be deemed to contain a Prohibited Substance in any such case where the Athlete proves by evidence that the concentration of the Prohibited Substance or its metabolites or markers and/or the relevant ratio(s) in the Athlete's Sample is attributable to a pathological or physiological condition.
Page 42 - Substance where the concentration of the Prohibited Substance or its metabolites or markers and/or any other relevant ratio(s) in the Athlete's Sample so deviates from the range of values normally found in humans that it is unlikely to be consistent with normal endogenous production.
Page 42 - ... whether the ratio is due to a physiological or pathological condition. In both cases, the investigation will include a review of any previous tests, subsequent tests and/or results of endocrine investigations. If previous tests are not available, the Athlete shall undergo an endocrine investigation or be tested unannounced at least three times within a three month period. Failure of the Athlete to co-operate in the investigations will result in considering the Athlete 's Sample to contain a Prohibited...
Page 42 - ... produced by the body naturally, a Sample will be deemed to contain such Prohibited Substance where the concentration of the Prohibited Substance or its metabolites or markers and/or any other relevant ratio(s) in the Athlete's Sample so deviates from the range of values normally found in humans so as not to be consistent with normal endogenous production. A Sample shall not be deemed to contain a Prohibited Substance in any such case where the Athlete proves by evidence that the...
Page 43 - A medical approval in accordance with section 7 of the International Standard for Therapeutic Use Exemptions is not valid if an Athlete's urine contains a diuretic in association with threshold or subthreshold levels of a Prohibited Substance(s). Diuretics include: acetazolamide, amiloride, bumetanide, canrenone, chlortalidone, etacrynic acid, furosemide, indapamide, mersalyl, spironolactone, thiazides (eg bendroflumethiazide, chlorothiazide...